Inventiva SA (IVA)
4.705
-0.20
(-3.98%)
USD |
NASDAQ |
Aug 28, 16:00
4.705
0.00 (0.00%)
After-Hours: 18:15
Inventiva Price to Book Value : 2.654 for Aug. 28, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 27, 2026 | 2.764 |
| August 26, 2026 | 2.719 |
| August 25, 2026 | 2.646 |
| August 24, 2026 | 2.651 |
| August 21, 2026 | 2.640 |
| August 20, 2026 | 2.623 |
| August 19, 2026 | 2.685 |
| August 18, 2026 | 2.617 |
| August 17, 2026 | 2.651 |
| August 14, 2026 | 2.595 |
| August 13, 2026 | 2.595 |
| August 12, 2026 | 2.640 |
| August 11, 2026 | 2.662 |
| August 10, 2026 | 2.679 |
| August 07, 2026 | 2.708 |
| August 06, 2026 | 2.629 |
| August 05, 2026 | 2.662 |
| August 04, 2026 | 2.544 |
| August 03, 2026 | 2.397 |
| July 31, 2026 | 2.527 |
| July 30, 2026 | 2.606 |
| July 29, 2026 | 2.544 |
| July 28, 2026 | 2.617 |
| July 27, 2026 | 2.595 |
| July 24, 2026 | 2.516 |
| Date | Value |
|---|---|
| July 23, 2026 | 2.544 |
| July 22, 2026 | 2.561 |
| July 21, 2026 | 2.527 |
| July 20, 2026 | 2.490 |
| July 17, 2026 | 2.606 |
| July 16, 2026 | 2.550 |
| July 15, 2026 | 2.522 |
| July 14, 2026 | 2.482 |
| July 13, 2026 | 2.426 |
| July 10, 2026 | 2.426 |
| July 09, 2026 | 2.555 |
| July 08, 2026 | 2.476 |
| July 07, 2026 | 2.572 |
| July 06, 2026 | 2.200 |
| July 02, 2026 | 2.206 |
| July 01, 2026 | 2.082 |
| June 30, 2026 | 2.132 |
| June 29, 2026 | 2.002 |
| June 26, 2026 | 1.924 |
| June 25, 2026 | 1.974 |
| June 24, 2026 | 1.952 |
| June 23, 2026 | 2.093 |
| June 22, 2026 | 1.980 |
| June 18, 2026 | 2.014 |
| June 17, 2026 | 1.991 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Nicox SA | -- |
| DBV Technologies SA | 3.843 |
| Cellectis SA | 8.411 |
| Genfit SA | -- |
| Innate Pharma SA | -- |
Price to Book Value Related Metrics
| PS Ratio | 145.07 |
| PEG Ratio | -0.2092 |
| Price | 4.705 |
| Earnings Yield | -60.38% |
| Market Cap | 909.18M |
| PEGY Ratio | -0.2092 |